ArticlePharmaceuticals (Basel, Switzerland)2025

Miraculin Can Contribute to a Reduction in Inflammatory Biomarkers and Cachexia in Malnourished Patients with Cancer and Taste Disorders.

Ana Isabel Álvarez-Mercado et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.